Delivery Order SPE2DB22D3501-SPE2DB25FXE86
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a contract ceiling value of $91,339.91. This is a firm fixed-price, non-competitive set-aside delivery order utilizing a competitive award process. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order falls...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 8, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a ceiling value of $20,853.10. This is a firm fixed price, competitively awarded delivery order without set-aside designation, to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. The delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is valued at $3,759.96 and carries a firm fixed price with an ultimate completion date of August 19, 2025. The award utilized competitive procurement procedures with no set-aside designation. The place of performance is identified as the vendor's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.32 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,784.73 and an ultimate completion date of September 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $3,133.30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which aligns with AmerisourceBergen's corporate headquarters location. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,639.94 by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, awarded on August 26, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, and this award was made through open competition without a set-aside designation. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials with a ceiling value of $12,533.20 by the Defense Logistics Agency on August 15, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 6, 2025, valued at $5,664.59 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of June 9, 2025 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $9,330.09 with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, serving federal defense and military healthcare...